Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Lumbar Spine Fusion Market by Product Type (Implants Instrumentation, Biomaterials), by Procedure (Traditional Surgery, Minimally-Invasive Surgery) and by End User (Hospitals, Ambulatory Surgical Centres): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03205

Pages: NA

Charts: NA

Tables: NA

Lumbar spine fusion is a form of surgical intervention, in which two or more vertebrae in the lower back are fused or joined so that the bone grows uniformly together and fuses the respective spine section. The process of this surgery involves placing small pieces of bone along the posterolateral gutter (back of the spine) or in in the disc space (front of the spine). Lumbar spine fusion is carried out to treat lower back pain that results from degenerative disc disease.

Increase in technological advancements in surgical devices supplements the market growth. Furthermore, a surge in the prevalence of spine related disorders and rise in global geriatric population boost the lumbar spine fusion market. However, stringent government regulations towards biomaterials and other devices used in surgery impede the growth of the market.

The global lumbar spine fusion market is segmented on the basis of product type, procedure, end user, and geography. By product type, this market is segmented into implants & instrumentation and biomaterials. By procedure this market is classified into traditional surgery and minimally invasive surgery. Furthermore, on the basis of end user, this market is categorised into hospitals, clinics, and ambulatory surgical centres. By geography, it has been analysed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as DePuy Synthes, Stryker Corporation, Zimmer Biomet, NuVasive, CONMED, Aesculap Implant Systems, LLC, Smith & Nephew, Globus Medical, Inc., ssur and Medtronic PLC have been provided in this report.

Key Benefits

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate imminent investment pockets.
  • It offers a quantitative analysis to enable stakeholders to capitalize on prevailing market opportunities.
  • Comprehensive analysis of all geographical regions has been provided to determine prevailing opportunities.
  • Key players have been profiled and their strategies thoroughly analyzed to understand the competitive outlook of the global market.
  • Extensive analysis by product elucidates the use of lumbar spine fusion devices in medical settings.

 Key Market Segments

  • By Product Type
    • Implants & Instrumentation
    • Biomaterials
  • By Procedure
    • Traditional Surgery
    • Minimally-Invasive Surgery
  • By End User
    • Hospitals
    • Ambulatory Surgical Centres
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Smith & Nephew
  • RTI Surgical Holdings, Inc.
  • Stryker Corporation
  • Medtronic PLC
  • NuVasive
  • Zimmer Biomet Holdings
  • Globus Medical, Inc.
  • CONMED
  • DePuy Synthes
  • Aesculap Implant Systems, LLC

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: LUMBAR SPINE FUSION MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Implants And Instrumentation

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Biomaterials

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: LUMBAR SPINE FUSION MARKET, BY PROCEDURE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Procedure

    • 5.2. Traditional Surgery

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Minimally-Invasive Surgery

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: LUMBAR SPINE FUSION MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Ambulatory Surgical Centres

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: LUMBAR SPINE FUSION MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product Type

      • 7.2.3. Market Size and Forecast, By Procedure

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Lumbar Spine Fusion Market

        • 7.2.6.1. Market Size and Forecast, By Product Type
        • 7.2.6.2. Market Size and Forecast, By Procedure
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Lumbar Spine Fusion Market

        • 7.2.7.1. Market Size and Forecast, By Product Type
        • 7.2.7.2. Market Size and Forecast, By Procedure
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Lumbar Spine Fusion Market

        • 7.2.8.1. Market Size and Forecast, By Product Type
        • 7.2.8.2. Market Size and Forecast, By Procedure
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product Type

      • 7.3.3. Market Size and Forecast, By Procedure

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Lumbar Spine Fusion Market

        • 7.3.6.1. Market Size and Forecast, By Product Type
        • 7.3.6.2. Market Size and Forecast, By Procedure
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Lumbar Spine Fusion Market

        • 7.3.7.1. Market Size and Forecast, By Product Type
        • 7.3.7.2. Market Size and Forecast, By Procedure
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Lumbar Spine Fusion Market

        • 7.3.8.1. Market Size and Forecast, By Product Type
        • 7.3.8.2. Market Size and Forecast, By Procedure
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Lumbar Spine Fusion Market

        • 7.3.9.1. Market Size and Forecast, By Product Type
        • 7.3.9.2. Market Size and Forecast, By Procedure
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Lumbar Spine Fusion Market

        • 7.3.10.1. Market Size and Forecast, By Product Type
        • 7.3.10.2. Market Size and Forecast, By Procedure
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Lumbar Spine Fusion Market

        • 7.3.11.1. Market Size and Forecast, By Product Type
        • 7.3.11.2. Market Size and Forecast, By Procedure
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Lumbar Spine Fusion Market

        • 7.3.12.1. Market Size and Forecast, By Product Type
        • 7.3.12.2. Market Size and Forecast, By Procedure
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product Type

      • 7.4.3. Market Size and Forecast, By Procedure

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Lumbar Spine Fusion Market

        • 7.4.6.1. Market Size and Forecast, By Product Type
        • 7.4.6.2. Market Size and Forecast, By Procedure
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Lumbar Spine Fusion Market

        • 7.4.7.1. Market Size and Forecast, By Product Type
        • 7.4.7.2. Market Size and Forecast, By Procedure
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Lumbar Spine Fusion Market

        • 7.4.8.1. Market Size and Forecast, By Product Type
        • 7.4.8.2. Market Size and Forecast, By Procedure
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Lumbar Spine Fusion Market

        • 7.4.9.1. Market Size and Forecast, By Product Type
        • 7.4.9.2. Market Size and Forecast, By Procedure
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Lumbar Spine Fusion Market

        • 7.4.10.1. Market Size and Forecast, By Product Type
        • 7.4.10.2. Market Size and Forecast, By Procedure
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Lumbar Spine Fusion Market

        • 7.4.11.1. Market Size and Forecast, By Product Type
        • 7.4.11.2. Market Size and Forecast, By Procedure
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Lumbar Spine Fusion Market

        • 7.4.12.1. Market Size and Forecast, By Product Type
        • 7.4.12.2. Market Size and Forecast, By Procedure
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Lumbar Spine Fusion Market

        • 7.4.13.1. Market Size and Forecast, By Product Type
        • 7.4.13.2. Market Size and Forecast, By Procedure
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Lumbar Spine Fusion Market

        • 7.4.14.1. Market Size and Forecast, By Product Type
        • 7.4.14.2. Market Size and Forecast, By Procedure
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product Type

      • 7.5.3. Market Size and Forecast, By Procedure

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Lumbar Spine Fusion Market

        • 7.5.6.1. Market Size and Forecast, By Product Type
        • 7.5.6.2. Market Size and Forecast, By Procedure
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Lumbar Spine Fusion Market

        • 7.5.7.1. Market Size and Forecast, By Product Type
        • 7.5.7.2. Market Size and Forecast, By Procedure
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Lumbar Spine Fusion Market

        • 7.5.8.1. Market Size and Forecast, By Product Type
        • 7.5.8.2. Market Size and Forecast, By Procedure
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Lumbar Spine Fusion Market

        • 7.5.9.1. Market Size and Forecast, By Product Type
        • 7.5.9.2. Market Size and Forecast, By Procedure
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Lumbar Spine Fusion Market

        • 7.5.10.1. Market Size and Forecast, By Product Type
        • 7.5.10.2. Market Size and Forecast, By Procedure
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Lumbar Spine Fusion Market

        • 7.5.11.1. Market Size and Forecast, By Product Type
        • 7.5.11.2. Market Size and Forecast, By Procedure
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. DePuy Synthes

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Stryker Corporation

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Zimmer Biomet Holdings

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. NuVasive

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. CONMED

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Aesculap Implant Systems, LLC

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Smith And Nephew

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Globus Medical, Inc.

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Medtronic PLC

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. RTI Surgical Holdings, Inc.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL LUMBAR SPINE FUSION MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL LUMBAR SPINE FUSION MARKET FOR IMPLANTS AND INSTRUMENTATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL LUMBAR SPINE FUSION MARKET FOR BIOMATERIALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL LUMBAR SPINE FUSION MARKET, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL LUMBAR SPINE FUSION MARKET FOR TRADITIONAL SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL LUMBAR SPINE FUSION MARKET FOR MINIMALLY-INVASIVE SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL LUMBAR SPINE FUSION MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL LUMBAR SPINE FUSION MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL LUMBAR SPINE FUSION MARKET FOR AMBULATORY SURGICAL CENTRES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL LUMBAR SPINE FUSION MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA LUMBAR SPINE FUSION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 15. U.S. LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 16. U.S. LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 17. U.S. LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 18. CANADA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 19. CANADA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 20. CANADA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 21. MEXICO LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 22. MEXICO LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 23. MEXICO LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. EUROPE LUMBAR SPINE FUSION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 25. EUROPE LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 28. FRANCE LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 29. FRANCE LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 30. FRANCE LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 31. GERMANY LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 32. GERMANY LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 33. GERMANY LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. ITALY LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 35. ITALY LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 36. ITALY LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 37. SPAIN LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 38. SPAIN LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 39. SPAIN LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. UK LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 41. UK LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 42. UK LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. RUSSIA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 44. RUSSIA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 45. RUSSIA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. REST OF EUROPE LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 47. REST OF EUROPE LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 48. REST OF EUROPE LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. ASIA-PACIFIC LUMBAR SPINE FUSION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 50. ASIA-PACIFIC LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 51. ASIA-PACIFIC LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 53. CHINA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 54. CHINA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 55. CHINA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 56. JAPAN LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 57. JAPAN LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 58. JAPAN LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. INDIA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 60. INDIA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 61. INDIA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH KOREA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH KOREA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH KOREA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. AUSTRALIA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 66. AUSTRALIA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 67. AUSTRALIA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. THAILAND LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 69. THAILAND LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 70. THAILAND LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. MALAYSIA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 72. MALAYSIA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 73. MALAYSIA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 74. INDONESIA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 75. INDONESIA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 76. INDONESIA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 77. REST OF ASIA PACIFIC LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 78. REST OF ASIA PACIFIC LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 80. LAMEA LUMBAR SPINE FUSION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 81. LAMEA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 82. LAMEA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 83. LAMEA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 84. BRAZIL LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 85. BRAZIL LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 86. BRAZIL LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 87. SOUTH AFRICA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 88. SOUTH AFRICA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 89. SOUTH AFRICA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 90. SAUDI ARABIA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 91. SAUDI ARABIA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 92. SAUDI ARABIA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 93. UAE LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 94. UAE LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 95. UAE LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 96. ARGENTINA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 97. ARGENTINA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 98. ARGENTINA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 99. REST OF LAMEA LUMBAR SPINE FUSION, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 100. REST OF LAMEA LUMBAR SPINE FUSION, BY PROCEDURE, 2025-2033 ($MILLION)
  • TABLE 101. REST OF LAMEA LUMBAR SPINE FUSION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 102. DEPUY SYNTHES: KEY EXECUTIVES
  • TABLE 103. DEPUY SYNTHES: COMPANY SNAPSHOT
  • TABLE 104. DEPUY SYNTHES: OPERATING SEGMENTS
  • TABLE 105. DEPUY SYNTHES: PRODUCT PORTFOLIO
  • TABLE 106. DEPUY SYNTHES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 108. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 109. STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 110. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 111. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. ZIMMER BIOMET HOLDINGS: KEY EXECUTIVES
  • TABLE 113. ZIMMER BIOMET HOLDINGS: COMPANY SNAPSHOT
  • TABLE 114. ZIMMER BIOMET HOLDINGS: OPERATING SEGMENTS
  • TABLE 115. ZIMMER BIOMET HOLDINGS: PRODUCT PORTFOLIO
  • TABLE 116. ZIMMER BIOMET HOLDINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. NUVASIVE: KEY EXECUTIVES
  • TABLE 118. NUVASIVE: COMPANY SNAPSHOT
  • TABLE 119. NUVASIVE: OPERATING SEGMENTS
  • TABLE 120. NUVASIVE: PRODUCT PORTFOLIO
  • TABLE 121. NUVASIVE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. CONMED: KEY EXECUTIVES
  • TABLE 123. CONMED: COMPANY SNAPSHOT
  • TABLE 124. CONMED: OPERATING SEGMENTS
  • TABLE 125. CONMED: PRODUCT PORTFOLIO
  • TABLE 126. CONMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. AESCULAP IMPLANT SYSTEMS, LLC: KEY EXECUTIVES
  • TABLE 128. AESCULAP IMPLANT SYSTEMS, LLC: COMPANY SNAPSHOT
  • TABLE 129. AESCULAP IMPLANT SYSTEMS, LLC: OPERATING SEGMENTS
  • TABLE 130. AESCULAP IMPLANT SYSTEMS, LLC: PRODUCT PORTFOLIO
  • TABLE 131. AESCULAP IMPLANT SYSTEMS, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. SMITH AND NEPHEW: KEY EXECUTIVES
  • TABLE 133. SMITH AND NEPHEW: COMPANY SNAPSHOT
  • TABLE 134. SMITH AND NEPHEW: OPERATING SEGMENTS
  • TABLE 135. SMITH AND NEPHEW: PRODUCT PORTFOLIO
  • TABLE 136. SMITH AND NEPHEW: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. GLOBUS MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 138. GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 139. GLOBUS MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 140. GLOBUS MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 141. GLOBUS MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 143. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 144. MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 145. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 146. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. RTI SURGICAL HOLDINGS, INC.: KEY EXECUTIVES
  • TABLE 148. RTI SURGICAL HOLDINGS, INC.: COMPANY SNAPSHOT
  • TABLE 149. RTI SURGICAL HOLDINGS, INC.: OPERATING SEGMENTS
  • TABLE 150. RTI SURGICAL HOLDINGS, INC.: PRODUCT PORTFOLIO
  • TABLE 151. RTI SURGICAL HOLDINGS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL LUMBAR SPINE FUSION MARKET SEGMENTATION
  • FIGURE 2. GLOBAL LUMBAR SPINE FUSION MARKET
  • FIGURE 3. SEGMENTATION LUMBAR SPINE FUSION MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN LUMBAR SPINE FUSION MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALLUMBAR SPINE FUSION MARKET
  • FIGURE 11. LUMBAR SPINE FUSION MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. LUMBAR SPINE FUSION MARKET FOR IMPLANTS AND INSTRUMENTATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. LUMBAR SPINE FUSION MARKET FOR BIOMATERIALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. LUMBAR SPINE FUSION MARKET SEGMENTATION, BY BY PROCEDURE
  • FIGURE 15. LUMBAR SPINE FUSION MARKET FOR TRADITIONAL SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. LUMBAR SPINE FUSION MARKET FOR MINIMALLY-INVASIVE SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. LUMBAR SPINE FUSION MARKET SEGMENTATION, BY BY END USER
  • FIGURE 18. LUMBAR SPINE FUSION MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. LUMBAR SPINE FUSION MARKET FOR AMBULATORY SURGICAL CENTRES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 23. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 24. COMPETITIVE DASHBOARD
  • FIGURE 25. COMPETITIVE HEATMAP: LUMBAR SPINE FUSION MARKET
  • FIGURE 26. TOP PLAYER POSITIONING, 2024
  • FIGURE 27. DEPUY SYNTHES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. DEPUY SYNTHES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. DEPUY SYNTHES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. STRYKER CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. ZIMMER BIOMET HOLDINGS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. ZIMMER BIOMET HOLDINGS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. ZIMMER BIOMET HOLDINGS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. NUVASIVE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. NUVASIVE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. NUVASIVE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. CONMED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. CONMED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. CONMED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. AESCULAP IMPLANT SYSTEMS, LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. AESCULAP IMPLANT SYSTEMS, LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. AESCULAP IMPLANT SYSTEMS, LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. SMITH AND NEPHEW: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. SMITH AND NEPHEW: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. SMITH AND NEPHEW: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. GLOBUS MEDICAL, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. GLOBUS MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. GLOBUS MEDICAL, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. MEDTRONIC PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. RTI SURGICAL HOLDINGS, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. RTI SURGICAL HOLDINGS, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. RTI SURGICAL HOLDINGS, INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Lumbar Spine Fusion Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved